SCHEMBL3665713

SCHEMBL3665713

Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])n1cnc2ccccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.52
▸ NPC1 O15118 4/20 0.47
▸ CYP1A2 P05177 2/20 0.47
▸ CYP3A4 P08684 2/20 0.47
▸ CYP2D6 P10635 2/20 0.47
▸ CYP2C9 P11712 2/20 0.47
▸ CYP2C19 P33261 2/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ WDR5 P61964 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ ENGASE Q8NFI3 2/20 0.46
▸ ATP1A1 P05023 2/20 0.46
▸ ATP1B1 P05026 2/20 0.46
▸ ATP1A3 P13637 2/20 0.46
▸ ATP1B2 P14415 2/20 0.46
▸ ATP4A P20648 2/20 0.46
▸ ATP1A2 P50993 2/20 0.46
▸ ATP4B P51164 2/20 0.46
▸ ATP1B3 P54709 2/20 0.46
▸ FXYD2 P54710 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5448791 0.84 MAPT (0.40) MAPTNPC1CYP2C9RAB9AWDR5
SCHEMBL5943999 0.82 MAPT (0.45) MAPTNPC1CYP2C9RAB9AWDR5
SCHEMBL6700831 0.78 MAPT (0.61) MAPTNPC1CYP1A2CYP3A4CYP2D6
SCHEMBL14344249 0.78 MAPT (0.61) MAPTNPC1CYP1A2CYP3A4CYP2D6
SCHEMBL6968592 0.78 MAPT (0.53) MAPTNPC1CYP1A2CYP3A4CYP2D6
SCHEMBL6325398 0.78 MAPT (0.53) MAPTNPC1CYP1A2CYP3A4CYP2D6
SCHEMBL6700823 0.78 MAPT (0.53) MAPTNPC1CYP1A2CYP3A4CYP2D6
SCHEMBL7235975 0.77 NPC1 (0.55) MAPTNPC1CYP1A2CYP3A4CYP2D6
SCHEMBL8501869 0.77 ALDH1A1 (0.34) MAPTNPC1CYP2C9RAB9AWDR5
SCHEMBL5634925 0.77 MAPT (0.34) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1306375-B1 SALTS OF BENZIMIDAZOLE COMPOUND AND APPLICATION THEREOF TAKEDA PHARMACEUTICAL (JP) 2006-10-11 — — EP claimed
EP-2227462-A1 CRYSTALLINE SOLVATED FORMS OF (R) -2- [[[3-METHYL-4- (2, 2, 2-TRIFLUOROETHOXY) -2-PYRIDINYL]METHYL]SULFINYL]-1H-BENZ IMIDAZOLE Takeda Pharmaceutical Company Limited (JP) 2010-09-15 — — EP disclosed
Send feedback